학술논문

Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial
Document Type
Article
Source
In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, July 2022, 22(7):1062-1075)
Subject
Language
English
ISSN
14744457
14733099